Funder
Deutsche Forschungsgemeinschaft
Publisher
Springer Science and Business Media LLC
Subject
Health Informatics,Epidemiology
Reference21 articles.
1. Cox DR. Regression models and life-tables. J Royal Stat Soc Ser B (Methodol). 1972; 34(2):187–220.
2. Lubsen J, Kirwan BA. Combined endpoints: can we use them?Stat Med. 2002; 21(19):2959–7290.
3. U.S. Department of Health and Human Services. Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), ICH. Guidance for Industry: E9 Statistical Principles for Clinical Trials. 1998. http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm073137.pdf . Accessed 23 Aug 2017.
4. Rauch G, Beyersmann J. Planning and evaluating clinical trials with composite time-to-first-event endpoints in a competing risk framework. Stat Med. 2013; 32(21):3595–608.
5. Bethel MA, Holman R, Haffner SM, Califf RM, Huntsman-Labed A, Hua TA, Murray J. Determing the most appropriate components for a composite clinical trial outcome. Am Heart J. 2008; 156(4):633–40.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献